Return On Equity of Esperion Therapeutics, Inc. from 31 Mar 2014 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Esperion Therapeutics, Inc. quarterly and annual Return On Equity in % history and change rate from 31 Mar 2014 to 30 Sep 2025.
  • Esperion Therapeutics, Inc. Return On Equity for the quarter ending 30 Sep 2025 was 25%, a 5% increase year-over-year.
  • Esperion Therapeutics, Inc. annual Return On Equity for 2024 was 15%, a 72% decline from 2023.
  • Esperion Therapeutics, Inc. annual Return On Equity for 2023 was 53%, a 34% decline from 2022.
  • Esperion Therapeutics, Inc. annual Return On Equity for 2022 was 81%, a 15% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Esperion Therapeutics, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 25% +1.2% +5% 01 Jul 2025 30 Sep 2025
Q2 2025 26% -0.5% -1.9% 01 Apr 2025 30 Jun 2025
Q1 2025 40% +17% +77% 01 Jan 2025 31 Mar 2025
Q4 2024 15% -39% -72% 01 Oct 2024 31 Dec 2024
Q3 2024 24% -34% -59% 01 Jul 2024 30 Sep 2024
Q2 2024 26% -41% -61% 01 Apr 2024 30 Jun 2024
Q1 2024 23% -54% -71% 01 Jan 2024 31 Mar 2024
Q4 2023 53% -27% -34% 01 Oct 2023 31 Dec 2023
Q3 2023 58% -36% -38% 01 Jul 2023 30 Sep 2023
Q2 2023 67% -26% -28% 01 Apr 2023 30 Jun 2023
Q1 2023 77% -7.4% -8.8% 01 Jan 2023 31 Mar 2023
Q4 2022 81% -14% -15% 01 Oct 2022 31 Dec 2022
Q3 2022 94% -25% -21% 01 Jul 2022 30 Sep 2022
Q2 2022 94% -103% -52% 01 Apr 2022 30 Jun 2022
Q1 2022 84% -146% -63% 01 Jan 2022 31 Mar 2022
Q4 2021 95% -1011% -91% 01 Oct 2021 31 Dec 2021
Q3 2021 120% +749% 01 Jul 2021 30 Sep 2021
Q2 2021 196% +468% 01 Apr 2021 30 Jun 2021
Q1 2021 231% +858% 01 Jan 2021 31 Mar 2021
Q4 2020 1106% +1205% 01 Oct 2020 31 Dec 2020
Q3 2020 -630% -546% -647% 01 Jul 2020 30 Sep 2020
Q2 2020 -271% -212% -355% 01 Apr 2020 30 Jun 2020
Q1 2020 -627% -579% -1190% 01 Jan 2020 31 Mar 2020
Q4 2019 -99% +35% +26% 01 Oct 2019 31 Dec 2019
Q3 2019 -84% +9.4% +10% 01 Jul 2019 30 Sep 2019
Q2 2019 -60% +17% +22% 01 Apr 2019 30 Jun 2019
Q1 2019 -49% +29% +37% 01 Jan 2019 31 Mar 2019
Q4 2018 -134% -58% -75% 01 Oct 2018 31 Dec 2018
Q3 2018 -94% -20% -27% 01 Jul 2018 30 Sep 2018
Q2 2018 -77% -14% -22% 01 Apr 2018 30 Jun 2018
Q1 2018 -77% -35% -81% 01 Jan 2018 31 Mar 2018
Q4 2017 -77% -48% -163% 01 Oct 2017 31 Dec 2017
Q3 2017 -74% -52% -241% 01 Jul 2017 30 Sep 2017
Q2 2017 -63% -44% -225% 01 Apr 2017 30 Jun 2017
Q1 2017 -43% -25% -136% 01 Jan 2017 31 Mar 2017
Q4 2016 -29% -13% -76% 01 Oct 2016 31 Dec 2016
Q3 2016 -22% -4.2% -24% 01 Jul 2016 30 Sep 2016
Q2 2016 -19% +2.2% +10% 01 Apr 2016 30 Jun 2016
Q1 2016 -18% +11% +37% 01 Jan 2016 31 Mar 2016
Q4 2015 -17% +30% +65% 01 Oct 2015 31 Dec 2015
Q3 2015 -18% +41% +70% 01 Jul 2015 30 Sep 2015
Q2 2015 -21% +24% +53% 01 Apr 2015 30 Jun 2015
Q1 2015 -29% +40% +58% 01 Jan 2015 31 Mar 2015
Q4 2014 -47% 01 Oct 2014 31 Dec 2014
Q3 2014 -59% 01 Jul 2014 30 Sep 2014
Q2 2014 -45% 01 Apr 2014 30 Jun 2014
Q1 2014 -69% 01 Jan 2014 31 Mar 2014

Esperion Therapeutics, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 15% -39% -72% 01 Jan 2024 31 Dec 2024
2023 53% -27% -34% 01 Jan 2023 31 Dec 2023
2022 81% -14% -15% 01 Jan 2022 31 Dec 2022
2021 95% -1011% -91% 01 Jan 2021 31 Dec 2021
2020 1106% +1205% 01 Jan 2020 31 Dec 2020
2019 -99% +35% +26% 01 Jan 2019 31 Dec 2019
2018 -134% -58% -75% 01 Jan 2018 31 Dec 2018
2017 -77% -48% -163% 01 Jan 2017 31 Dec 2017
2016 -29% -13% -76% 01 Jan 2016 31 Dec 2016
2015 -17% +30% +65% 01 Jan 2015 31 Dec 2015
2014 -47% 01 Jan 2014 31 Dec 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.